G0123 Insurance Policy Changes

HCPCS G0123 is officially defined as "Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision." HCPCS G0123 is referenced in 2 tracked payer policy changes from Blue Cross Blue Shield of Rhode Island and Blue Cross of Idaho. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0123 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.